IRIS
AQUARO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.759
EU - Europa 1.792
AS - Asia 300
SA - Sud America 13
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 18.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.744
RU - Federazione Russa 290
SE - Svezia 288
DE - Germania 274
UA - Ucraina 222
IE - Irlanda 171
CN - Cina 169
IT - Italia 137
FR - Francia 108
PL - Polonia 92
GB - Regno Unito 86
FI - Finlandia 51
KR - Corea 49
BE - Belgio 42
SG - Singapore 38
CZ - Repubblica Ceca 18
CA - Canada 15
VN - Vietnam 11
IN - India 8
BR - Brasile 6
JP - Giappone 6
AU - Australia 4
CL - Cile 4
UZ - Uzbekistan 4
EU - Europa 3
MY - Malesia 3
NL - Olanda 3
RO - Romania 3
CH - Svizzera 2
ES - Italia 2
GH - Ghana 2
HK - Hong Kong 2
KG - Kirghizistan 2
TR - Turchia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CI - Costa d'Avorio 1
EC - Ecuador 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
SC - Seychelles 1
TH - Thailandia 1
Totale 18.878
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.841
Wilmington 4.549
Houston 4.030
Ann Arbor 635
Fairfield 492
Chandler 428
Moscow 250
Ashburn 246
Seattle 220
Jacksonville 207
Cambridge 158
Dublin 156
Medford 113
Kraków 92
Dearborn 79
Beijing 72
Lawrence 54
Rome 49
New York 45
Brussels 42
Mülheim 36
Menlo Park 31
Boardman 30
Singapore 22
Palo Alto 21
Zhengzhou 21
San Diego 19
Milan 17
Redwood City 13
Olomouc 12
Kunming 11
San Mateo 11
Guangzhou 10
Norwalk 10
Mountain View 9
Hefei 8
Toronto 8
West Jordan 8
Dong Ket 7
Munich 7
Nanjing 7
Phoenix 7
University Park 7
Brno 6
Detroit 6
Helsinki 6
Jinan 6
São Paulo 6
Falls Church 5
Kilburn 5
London 5
San Francisco 5
Seoul 5
Verona 5
Auburn Hills 4
Hanoi 4
Hebei 4
Pune 4
Shanghai 4
Amsterdam 3
Andover 3
Buzau 3
Cedarhurst 3
Creede 3
Genzano di Roma 3
Kuala Lumpur 3
Mississauga 3
Nuremberg 3
Nürnberg 3
Prescot 3
Stockholm 3
Wuhan 3
Ypsilanti 3
Accra 2
Bari 2
Bengaluru 2
Chicago 2
Chongqing 2
Clearwater 2
Hanover 2
Hong Kong 2
Indiana 2
Kampala 2
Lappeenranta 2
Le Havre 2
Nanchang 2
Ottawa 2
Portici 2
Potenza 2
Saint Petersburg 2
San Jose 2
Shenyang 2
Sydney 2
Tappahannock 2
Vaxjo 2
Washington 2
Wenzhou 2
Yellow Springs 2
Abidjan 1
Alghero 1
Totale 17.264
Salva come PNG Salva come JPEG
Nome #
1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY 714
Therapeutic strategies towards HIV-1 infection in macrophages 467
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 447
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 443
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 433
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 432
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 424
Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: Role of cells of monocyte-macrophage lineage 423
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 417
Understanding HIV compartments and reservoirs 416
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines 413
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems 413
HIV-1-associated dementia during HAART therapy 410
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 410
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 398
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 396
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 392
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 391
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: Evaluation of new 6-desfluoroquinolone derivatives 390
Antiviral profile of HIV inhibitors in macrophages: Implications for therapy 388
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 384
Influenza virus A (H5N1): A pandemic risk? 383
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies 382
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 378
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 375
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 373
Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals 372
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 367
The role of HIV infection in neurologic injury 367
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages 366
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 366
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 364
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 363
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 361
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 353
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 350
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 346
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 346
NeuroAIDS: virological aspects of HIV infection 345
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 344
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates 341
Identification of the novel KI polyomavirus in paranasal and lung tissues 341
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 335
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 307
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 292
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 266
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 239
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 164
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 158
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 156
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 153
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 148
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 97
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 39
Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection 24
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 21
Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers 15
POTENT ANTIVIRAL ACTIVITY OF NEW GENERATION HIV-1 MATURATION INHIBITORS ON HUMAN PRIMARY CELLS 8
Totale 19.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.069 440 376 353 478 421 513 490 444 454 421 320 359
2020/20213.120 351 340 328 374 291 312 502 316 70 67 111 58
2021/2022751 31 49 87 55 20 78 33 28 86 92 29 163
2022/20231.096 96 89 18 164 91 215 65 72 105 4 67 110
2023/2024448 64 142 20 10 43 59 16 17 4 12 4 57
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 19.006